LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0800
+0.0120 (17.65%)
Feb 26, 2026, 10:12 AM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $2.8 million as of February 26, 2026. Its market cap has decreased by -93.74% in one year.
Market Cap
2.80M
Enterprise Value
56.04M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 2.80M, a decrease of -98.77%. That is a compound annual growth rate of -61.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 2.80M | -91.90% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 4.64M |
| AXIM Biotechnologies | 4.15M |
| Enzon Pharmaceuticals | 4.10M |
| Burzynski Research Institute | 3.42M |
| Clearside Biomedical | 3.21M |
| ProtoKinetix | 3.19M |
| Enzolytics | 2.90M |
| Vaccinex | 2.76M |